CA3226836A1 - Method of treating veterinary viral diseases - Google Patents

Method of treating veterinary viral diseases Download PDF

Info

Publication number
CA3226836A1
CA3226836A1 CA3226836A CA3226836A CA3226836A1 CA 3226836 A1 CA3226836 A1 CA 3226836A1 CA 3226836 A CA3226836 A CA 3226836A CA 3226836 A CA3226836 A CA 3226836A CA 3226836 A1 CA3226836 A1 CA 3226836A1
Authority
CA
Canada
Prior art keywords
animal
virus
days
feline
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3226836A
Other languages
English (en)
French (fr)
Inventor
Edward Murray
Ralf Warrass
Joachim Ullrich
Basav Hangalapura Nagaraj
Willem Huisman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CA3226836A1 publication Critical patent/CA3226836A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA3226836A 2021-08-06 2022-08-05 Method of treating veterinary viral diseases Pending CA3226836A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21190172.3 2021-08-06
EP21190172 2021-08-06
EP22185716 2022-07-19
EP22185716.2 2022-07-19
PCT/EP2022/072074 WO2023012329A1 (en) 2021-08-06 2022-08-05 Method of treating veterinary viral diseases

Publications (1)

Publication Number Publication Date
CA3226836A1 true CA3226836A1 (en) 2023-02-09

Family

ID=83151800

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3226836A Pending CA3226836A1 (en) 2021-08-06 2022-08-05 Method of treating veterinary viral diseases

Country Status (8)

Country Link
US (1) US20240342204A1 (OSRAM)
EP (1) EP4380578A1 (OSRAM)
JP (1) JP2024528237A (OSRAM)
AU (1) AU2022323465A1 (OSRAM)
BR (1) BR112024002195A2 (OSRAM)
CA (1) CA3226836A1 (OSRAM)
MX (1) MX2024001645A (OSRAM)
WO (1) WO2023012329A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023002233A (es) 2020-08-24 2023-03-15 Gilead Sciences Inc Compuestos fosfolipidos y usos de estos.
TWI811812B (zh) 2020-10-16 2023-08-11 美商基利科學股份有限公司 磷脂化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0411900B8 (pt) 2003-06-26 2021-05-25 Biotron Ltd compostos e composições farmacêuticas compreendendo os mesmos
WO2012152317A1 (en) 2011-05-10 2012-11-15 Okapi Sciences Nv Compounds for use in the treatment of feline retroviral infections
GB201203180D0 (en) 2012-02-24 2012-04-11 Okapi Sciences Nv Compounds for treating parvovirus infection
IL296496B2 (en) 2014-12-26 2024-10-01 Univ Emory N4-hydroxycytidine and derivatives and anti-viral uses related thereto
KR102626210B1 (ko) 2017-12-07 2024-01-18 에모리 유니버시티 N4-하이드록시사이티딘 및 유도체 및 이와 관련된 항-바이러스 용도
IL277160B2 (en) 2018-03-07 2024-10-01 Univ Emory 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Also Published As

Publication number Publication date
WO2023012329A1 (en) 2023-02-09
EP4380578A1 (en) 2024-06-12
AU2022323465A1 (en) 2024-02-01
US20240342204A1 (en) 2024-10-17
JP2024528237A (ja) 2024-07-26
BR112024002195A2 (pt) 2024-04-30
MX2024001645A (es) 2024-02-27

Similar Documents

Publication Publication Date Title
Higgins et al. The equine manual E-book: the equine manual E-book
Johnson Fueling the immune response: what’s the cost?
JP2017525681A (ja) パラミクソウイルスの治療方法
US20240342204A1 (en) Method of treating veterinary viral diseases
JP7065030B2 (ja) Ｒｓｖの処置のための組合せ製品
KR20190021334A (ko) 감염성 기관지염 바이러스에 대한 백신
KR101929141B1 (ko) 돼지 사료에서의 나라신의 항바이러스 효과
KR20160093046A (ko) 로소니아 인트라셀룰라리스 및 돼지 써코바이러스 2에 대한 백신
Pastoret et al. Veterinary vaccines for animal and public health
EP1140103B1 (en) Ponazuril for treating neurologic and abortigenic diseases caused by coccidia.
TW201731526A (zh) 混成核心之貓科動物疫苗
JP7293225B2 (ja) 組合せ製品を用いるｒｓｖの処置
Webster et al. Vaccination as a strategy to reduce the emergence of amantadine-and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus
CN117858710A (zh) 治疗兽医学病毒性疾病的方法
RU2546247C2 (ru) Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
CN102869380A (zh) 用于禽舍疾病的活疫苗
US20240327339A1 (en) Compositions and methods for treating and preventing viral infections
JP4991076B2 (ja) 住肉胞子虫、ネオスポラ、トキソプラズマおよびイソスポラによる疾患処置のためのプラジカンテル化合物
Crawford et al. Efficacy of ivermectin administration to growing pigs after a virulent porcine reproductive and respiratory syndrome virus 1-4-4 L1C challenge
CN114901293A (zh) 用于预防或治疗幼小的哺乳动物得与黏膜相关的传染性疾病的血清组成物的制造方法、通过该方法制造的血清组成物及其用途
RU2292220C1 (ru) Способ профилактики инфекционного ринотрахеита и парагриппа-3 крупного рогатого скота
Kirkland et al. Paramyxoviruses: rubulavirus, Menangle, and Nipah virus infections
KR102065848B1 (ko) 엔테로코코스 카니테스티니(Enterococcus canintestini)균주를 함유하는 항인플루엔자 바이러스 조성물
Jaramillo Immune Response and Protection Against BVDV-2 and BHV-1 Infection Elicited by Modified-Live Virus Vaccination in Dairy Calves. Effects of Vaccination Route and Trace Mineral Injection
WO2024097158A1 (en) Viral prophylaxis treatment methods and pre-exposure prophylaxis kits

Legal Events

Date Code Title Description
R00 Party data change recorded

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R00-R116 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPOINTMENT OF AGENT REQUEST

Effective date: 20241119

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R00-R119 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REVOCATION OF AGENT REQUEST

Effective date: 20241119

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250319

R17 Change to representative recorded

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R17-R121 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REVOCATION OF AGENT REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250422

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R17-R117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPOINTMENT OF AGENT REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250422

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250422

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250709

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250709